3rd Digital Strategy & Innovation for Medical Affairs Summit

Create a Digital Cultural Transformation Within Medical Affairs

February 23-24, 2021

Online LIVE Stream

Event Overview

With a greater demand for deep scientific information across the healthcare community, it’s critical for medical affairs teams to upskill and stay relevant as consumers use new channels to absorb information. Learn to transform your medical affairs department, implement progressive policies, push patient centricity, and determine what it takes to demonstrate value to internal and external stakeholders in a digital era. 

For the 3rd Annual DGE Digital Strategy & Innovation for Medical Affairs Summit, we’ve partnered with the brightest in the industry to build a program that focuses on the cultural digital transformation in medical affairs. Join us for the opportunity to participate in an interactive meeting that will help to identify best practices when implementing a digital strategy within your medical affairs team. 

Hilton East Brunswick

Image

3 Tower Center Blvd.
East Brunswick, NJ 08816

(732) 828-2000

Hotel Website

About the Chairperson

Image

Dr. Matthew T. Roe has been a faculty member at Duke University School of Medine and the Duke Clinical Research Institute (DCRI) since 1999. As a senior investigator at the DCRI, he has been the principal investigator for numerous phase II-IV cardiovascular clinical trials and is currently a co-principal investigator for the ADAPTABLE trial—the first large-scale pragmatic trials being conducted in the PCORnet network. He has also served in leadership roles for several observational registries focusing upon the treatment and outcomes of patients with cardiovascular disease and has served as the Director of the DCRI Clinical Research Fellowship since 2010.

Featured Speakers

Image

Craig Lipset

Head of Clinical Innovation
Pfizer

Image

Jeff Kingsley

Chief Executive Officer
IACT Health 

Image

Dawn Anderson

Managing Director, Life Sciences Strategy and Operations, R&D Practice
Deloitte

Image

Ross Friedberg

General Counsel & Chief Privacy Officer
Doctor on Demand

Top Reasons to Attend

  1. Understand the current landscape and what companies are doing with digital strategy
  2. Learn about new digital strategies and how to implement them
  3. Gain a clear understanding of what can be done successfully today in Med Affairs with digital
  4. Learn about ongoing digital initiatives across the industry
  5. Bring back innovative ideas to share data with your team
  6. Updates on digital innovation applications in pharma
  7. Discuss what new digital initiatives medical affairs colleagues are launching in Biotech/Pharma
  8. Examine ideas for sharing real time, on demand scientific content
  9. Learn about digital med info efforts
  10. Discuss budget/pricing for digital innovation applications, implementation challenges and key learnings from successes & failures

Attendee Profile

Current medical affairs professionals:

  • Field Medical Team
  • MSL
  • Medical Affairs
  • Medical Communication
  • Medical Information
  • Digital Strategy
  • Medical Director
  • Medical Advisor
  • Medical Liaison
  • Medical Advisor
  • MSL Coordinator
  • Clinical Development
  • Publications
  • Medical Education Manager
  • Global Medical Affairs
  • Medical Manager
  • Those professionals working within Clinical Development, Research & Development and are transitioning to a medical affairs role
  • Physicians, pharmacists, and PhD professionals wishing to transition into the pharmaceutical industry

Tuesday

February 23rd, 2021 | Day 1

8:30 AM - 8:45 AM

Login

8:45 AM - 9:00 AM

Introduction from Chairperson

Charles Makin - Global Head, Real World Evidence Strategy
BIOGEN

 

PART 1: AN OVERVIEW OF INVESTING IN DIGITAL TOOLS AND STRATEGIES

9:00 AM - 9:30 AM

Convince Organizations to Make the Digital Investment Choices You Need

With costs at an all-time high and revenue decreasing, securing buy-in for new digital tools and strategies may seem like a daunting task. It is crucial to showcase that the cost of investing is worth the outcome. Medical affairs teams need to align a strategy to communicate the value of these tools to their organizations.

  • Examine and identify business needs to create a business case to showcase the benefits and how costs will go down in the future
  • Understand the reimbursement landscape
  • Identify how certain tools bring value to consumers and help you stay competitive
  • Set up the conversation with the appropriate stakeholders

Anand Reddi - Director of Digital Innovation, Global Commercial Strategy and Operations
GLAXOSMITHKLINE

Barry Lubarsky - Executive Director, Medical Affairs Strategy
ALKERMES

9:30 AM - 10:15 AM

PANEL: Secure Regulatory Buy-In for Virtual Engagement

To convince organizations to pursue new digital strategies, you must first assure legal and regulatory approval. The challenge is determining how to align these tools and strategies with regulatory to stay in compliance.

  • Navigate privacy and security concerns in a virtual setting
  • Balance novel innovation with compliance and regulatory guardrails
  • Partner to build a digital regulatory strategy 
  • Expand remote monitoring and other flexibility that FDA has allowed for clinical studies due to COVID
  • Discuss recent changes in remote monitoring from a medical device or medical app standpoint

Jon Ward - Medical Director
NOVARTIS

David Pudwill - Senior Director, Regulatory Affairs
CONVATEC

Doreen Morgan - Vice President, Global Regulatory
MESOBLAST

Lee Severson - Associate Director, Global Regulatory Lead, Global Product Strategy
CSL BEHRING

10:15 AM - 10:30 AM

Break

10:30 AM - 11:00 AM

Upskill and Train Medical Affairs Teams to Navigate a Digital Era

Medical affairs teams are accustomed to in-person interactions, and these team members need to upskill and stay relevant to the new channels utilized by consumers. It is essential to consistently demonstrate value to internal and external stakeholders in a digital era.

  • Learn how to utilize the platforms that are available
  • Capture the audience and convey messages in a clear and concise way
  • Stay current with information by recognizing what is important and what is not
  • Engage with other medical affairs professionals to determine what tools work best
  • Change existing behavior and adapt to new, innovative tools to add value
  • Assist with interpretation and allow sharing of diagnostics among HCPs

Ajit Kulkarni - Associate Director, Medical Science Liaison
NOVARTIS

11:00 AM - 11:30 PM

Advocate for New Technologies in Diagnostics Testing

There is an evolving opportunity for innovative technological solutions in diagnostic testing that can impact both patients and providers. Medical Affairs is a key stakeholder in driving digital solutions. Digital tools can improve data accessibility and sharing, providing an integrated experience for HCPs and meaningful outcomes for patients. 

  • Improve the patient journey through the development and implementation of a virtual assistant
  • Leverage at-home diagnostics with wearable devices
  • Assist with interpretation and allow sharing of diagnostics among HCPs

Timothy Schwartz - Senior Scientific Affairs Manager, Next Generation Sequencing
ROCHE

Sheetal Parmar - VP, Medical Affairs
NATERA

11:30 AM - 12:15 PM

PANEL: Envision the Best Tools for Connecting with Millennials

Millennials are currently the largest segment of the workforce and are rapidly changing the face of healthcare. They will soon have the strongest purchasing power of any generation. They are known for being tech-savvy and innovative and prefer to use digital channels to consume information and engage with pharmaceutical companies. The future of medicine will be directed by millennials and it is imperative to learn new skills to connect with them.

  • Promote platforms that provide video
  • Ensure all digital tools and platforms can be accessed from smartphones 
  • Create and utilize mobile apps
  • Connect healthcare to wearable devices such as Apple watches and Fitbits

Kunal Ramani - Regional Medical Affairs Director
XERIS PHARMACEUTICALS

Stevan Tomich - Regional Medical Affairs Director
XERIS PHARMACEUTICALS

Maria Picone - Co-Founder/CEO
TREND COMMUNITY ENGAGEMENT

12:15 PM - 12:45 PM

Lunch

12:45 PM - 1:15 PM

Best Practices: Tailoring Medical Affairs Deliverables to the Less Digitally-Savvy KOL

In the post-COVID era, physician practice patterns in largely outpatient settings have shifted focus to maximizing clinical hours in an effort to maintain income leaving healthcare providers less time and patience to learn new technology or new medical information. 

  • Describe best practices for designing and executing remote advisory boards and KOL interactions
  • Discuss ways to leverage technology to streamline training and learning curves related to new scientific information 
  • Utilize animation and leverage CME disease state “microsites” to drive on-going multi-media, on-demand medical education

Martina Cartwright - Senior Director, Medical Affairs
CASSIOPEA

1:15 PM - 1:45 PM

Digital Strategy for Medical and Scientific Engagement in the Small/Mid-Sized Company

In the age of all things digital, medical and scientific affairs organizations must consistently evolve their communication strategies to be able to continue to engage and improve their ability to attract and communicate with Key Opinion Leaders and Thought Leaders in their field. This can be particularly challenging in the small to mid-sized company where resources are limited in both access to software tools and platforms and dedicated personnel to manage and maintain the communication efforts. This presentation will describe how one company developed and adopted a strategy based on that used by marketing organizations for Scientific Content Marketing, and modeling communication pathways based on the customer journey.

  • Utilize various forms of communication
  • Analyze digital strategy development and execution
  • Discuss hits and misses – the results achieved in the first years and how it influenced the path forward

Sherry Dunbar - Senior Director, Global Scientific Affairs
LUMINEX CORPORATION

1:45 PM - 2:00 PM

Break

2:00 PM - 2:45 PM

PANEL: Switch From In-Person Conferences to Virtual

The future is moving in the direction of conducting more virtual conferences. Virtual conferences are more time-efficient for HCPs who are busy. They also reduce travel costs and carbon footprints. What does the future look like for virtual conferences?

  • Replicate a live setting which allows for a rich environment and live presence from pharma and biotech companies
  • Recreate the same activities as live events
  • Incorporate interactive collaboration tools that allows for the same type of engagement among peers

Jennifer Guzman - Senior Director, Medical Affairs Strategy
HELIXMITH

Ana Bozas - Associate Director, Global Medical Communications
AKCEA THERAPEUTICS

Alyson Evans - Associate Director/MSL
BIOHAVEN PHARMACEUTICALS

Daniel Snyder - Vice President, Medical Affairs
UROVANT SCIENCES, INC.

2:45 PM - 3:15 PM

Develop a Data-Driven Approach to Medical Affairs

Many medical affairs teams underestimate the value of the data that they create and consume. The utility of analytics is often misunderstood and developing a data strategy can be overwhelming. As biotech embraces more digital solutions, an investment into data-driven decision making and a self-service analytics model becomes crucial in showcasing ROI and value.

  • Understand the gaps, opportunities, data silos, and current data landscape of your team
  • Start small and utilize a structured framework to bring data to the hands of your users to increase adoption and create a data-oriented department
  • Avoid investing in “shiny” AI/ML vendors or projects without having a defined ROI and business use case
  • Case Study 1: Natural Language Processing in Medical Information & Field Medical
  • Case Study 2: Descriptive/Predictive Capabilities of Medical-Legal-Regulatory data in Medical Affairs Operations      

Imtiyaz Hossain - Associate Director, Data Science Lead, Global Medical Affairs
TAKEDA

Claudia Morato - Senior Global Medical Affairs, Oncology
ELI LILLY & COMPANY

3:15 PM - 3:45 PM

Strategize How to Create a Medical Presence in the Digital World

More than ever before, medical affairs teams are looking for ways to engage digitally with customers both by creating and utilizing existing tools and platforms. The expanding market landscape creates a broad spectrum of information leaving HCPs to determine the best resources for their needs.

  • Learn how to differentiate your digital strategy to fill in the gaps in a digital world
  • Determine the best tools to fit your company’s needs

Nami Pandit - Global Medical Affairs Director
SANOFI GENZYME

3:45 PM - 4:15 PM

Secure Regulatory Buy-In for Virtual Engagement

In order to convince organizations to adopt and invest in new digital tools and strategies, they must ensure that it is approved by legal and regulatory. The challenge is determining how to align these tools and strategies with regulatory to stay in compliance.

  • Navigate privacy and security concerns in a virtual setting
  • Use platforms that are validated and systems that capture all of the data
  • Align digital tools with regulatory by creating them synergistically with regulatory affairs

Ritam Priya - Vice President and Regulatory
NOCIMED

Wednesday

February 24th, 2021 | Day 2

8:30 AM - 8:45 AM

Login

8:45 AM - 9:00 AM

Chairperson’s Recap of Day One

 

PART 2: CONNECT WITH ONLINE COMMUNITIES TO ALIGN WITH BUSINESS STRATEGY

9:00 AM - 9:30 AM

Blaze New Trails for Social Media in Healthcare

Social media can be an effective way for HCPs to stay connected, communicate, and market products or services. These sites are becoming more prevalent in reaching out to consumers and other HCPs. Social media has an enormous user base that can be targeted by the healthcare market.

  • Access and share information quickly
  • Provide information in bite-sized pieces
  • Evaluate competitors to gain insight to compare and improve quality
  • Track KOLs and observe their behavior to assist with your business strategy

Maria Urso - Director, Medical Affairs Field Team
EXACT SCIENCES

Jason Howard - Scientific Engagement and Medical Lead
SANOFI

9:30 AM - 10:15 AM

PANEL: Drive Advances in Patient-Centricity

Creating a patient-centric solution requires feedback from the patients, guiding decisions based on their needs and perspectives. It is imperative to establish a connection with other practitioners, patients, and their families to adopt and implement a business strategy to optimize patient outcomes. 

  • Partner with online communities
  • Explore how social listening can be used to collect valuable insight from patients
  • Personalize digital communication based on their specific questions and needs
  • Create a menu of digital materials for patients to find the information they need

Maria Picone - Co-Founder/CEO
TREND COMMUNITY ENGAGEMENT

Antonio Maltese - Intern
TREND COMMUNITY ENGAGEMENT

Rachael Brake - Head, US Medical Affairs, Oncology
TAKEDA

10:15 AM - 10:30 AM

Break

10:30 AM - 11:15 AM

Develop and Implement Digital Strategies That Align With Target Audience Preferences

Everyone digests information differently and have different preferences on how they like to receive information and learn. Understand the audience you want to reach, how they learn in the digital age, and how to increase their engagement via digital content. 

  • Conduct market research to find out who your audience is
  • Reach out to KOL base and identify where they go for their information
  • Have a dynamic feedback loop with customers to gain insights
  • Develop tailored digital innovation to cater to specific audiences for digital content
  • Examine which digital assets best fit the data type/scientific messages and are most effective to reach goals for successful ROI
  • Link metrics to digital assets to understand which content is most engaging to apply learnings for updating and/or developing digital assets

Kunj Gohill - Director, Digital Strategy Lead, Digital Medical Affairs
NOVARTIS

Jamie L. Weiss - Head of Global Publications, Global Medical Affairs
LEO Pharma

11:15 AM - 12:00 PM

PANEL: Maintain Meaningful Engagement Online

In-person communication and engagement is moving towards being replaced by online platforms. The struggle for many HCPs is maintaining a rich and meaningful experience with customers and KOLs in a digital setting. Without a physical presence, HCPs must find new ways to have a virtual interaction that is still meaningful.

  • Use collaborative tools that allow presenters to work with the audience and large groups of people
  • Utilize audience-response systems to ask questions and collect answers digitally
  • Identify what tools work best for certain individuals

Tyke White - Vice President, Scientific Engagement and Medical Information
ALKERMES

Svetlana Pidasheva - Senior Director, Scientific Affairs
AXCELLA

Sherin Al-Safadi - Global Medical Affairs Strategy Lead, Oncology
BAYER PHARMACEUTICALS

Elizabeth Pash - Vice President, Medical Affairs
GELESIS

12:00 AM - 12:45 PM

PANEL: Secure Meetings with KOLs by Using Content-Driven Engagement

Securing meetings in a virtual setting has its own set of challenges in comparison to meeting in person. MSLs rely on a relationship-based exchange, where the relationship of an MSL and a KOL will dictate whether the meeting is accepted. Doing this virtually has changed this type of exchange. How do you secure meetings with KOLs virtually?

  • Be proactive in your request to meet
  • Plan good content to capture the attention of KOLs
  • Create content for MSLs to present the information of materials that will be discussed
  • Use the content of what will be shared instead of relying on the relationship

Suzanne Giordano - Executive Director and Head of MSLs
SUNOVION PHARMACEUTICALS

Sherry Siegert - Director, Medical Affairs
LA JOLLA PHARMACEUTICAL COMPANY

Wendy Wells - Director, Medical Affairs Training
APELLIS PHARMACEUTICALS

12:45 PM - 1:15 PM

Lunch

1:15 PM - 1:45 PM

Track KOLs Virtually to Benefit from Their Networks

Traditionally, thought leaders were tracked by looking at publications. In today’s world, digital and social media influencers are the emerging thought leaders.

  • Monitor the activity of KOLs on social media sites 
  • Identify their preferred groups
  • Find out who they network with through social feeds
  • Examine their opinions and how they think by reading their posts and links

Tina Purcell - Associate Director, Medical Science Liaison, Oncology
ASTELLAS PHARMA

1:45 PM - 2:30 PM

PANEL: Assist Medical Affairs Teams in Everyday Work Life with Innovative Tools and Platforms

Medical affairs teams have an overload of responsibilities.  Well-guided innovation can empower these individuals to create a more efficient and seamless workflow.

  • Tag and categorize insights for easier storage and access
  • Explore virtual advisory boards with polling and white board sessions 
  • Replace lengthy presentations and reading formats
  • Identify insights and trends
  • Take advantage of social media platforms for health care professionals
  • Implement digital strategies for post-market research

Peter Covitz - Senior Director, Medical Affairs
BIOGEN

Shurjeel Choudhri - Senior Vice President and Head, Medical and Scientific Affairs
BAYER

Luca Dezzani - Vice President, U.S. Medical Affairs
EISAI

2:30 PM - 3:15 PM

PANEL: Reinvent Medical Education with Digital Approaches

Medical education is rapidly shifting from in-person classes to increase the accessibility of information digitally. New channels need to be optimized for medical education. 

  • Provide CME/MIME on the go for HCPs needing access
  • Allow information online to be accessed for longer periods of time
  • Utilize audibles during commute time

Becky Winslow - Senior Clinical Specialist, Pharmacogenomics, Medical Affairs
ADMERA HEALTH

Marissa Caputo - Director of Medical Education and Medical Affairs
CORINDUS VASCULAR ROBOTICS

Ivan Desviat - Director, Medical Education & Outcome Measures Excellence
ABBVIE

3:15 PM - 3:30 PM

Break

3:30 PM - 4:00 PM

Ditch the 100-Pound Toolbox: Finding the Best Digital Tools for Your Team

Medical affairs teams are overwhelmed with the sheer quantity of available digital tools and platforms. How can medical affairs digital leaders identify and implement a working, fit-for-future digital strategy? 

  • Identify the team’s business needs and deliverables
  • Assess the team’s learning styles and strengths, and optimize information delivery to them
  • Consider whether to integrate multiple interfaces into a single platform for organization and easy access; and whether to leave them alone

Michael Kahn - Medical Affairs Operations Leader
SPARK THERAPEUTICS

4:00 PM - 4:30 PM

Identify the Digital Tools That are Here to Stay Post-COVID

The digital landscape of healthcare has accelerated due to Covid-19. Many organizations that were not up-to-date with the latest digital tools and strategies were left fumbling to find fast solutions to navigating healthcare in a digital environment. Covid-19 will eventually come to an end but there are many digital tools that are here to stay.

  • Continue providing care for patients with the use of electronic communications and software without an in-person visit
  • Empower virtual engagement and conferences among HCPs 
  • Collect insights via artificial intelligence 
  • Support 3D virtual reality platforms that replicate live meetings
  • Encourage collaboration tools that allow for big groups to work together

Edmond Kim - Global MCC Director, Medical Communications
AMGEN

FEATURED SPEAKERS

Image

Charles Makin

BIOGEN

Global Head, Real World Evidence Strategy

Image

Anand Reddi

GLAXOSMITHKLINE

Director of Digital Innovation, Global Commercial Strategy and Operations

Image

Barry Lubarsky

ALKERMES

Executive Director, Medical Affairs Strategy

Image

Jon Ward

NOVARTIS

Medical Director

Image

David Pudwill

CONVATEC

Senior Director, Regulatory Affairs

Image

Doreen Morgan

MESOBLAST

Vice President, Global Regulatory

Image

Lee Severson

CSL BEHRING

Associate Director, Global Regulatory Lead, Global Product Strategy

Image

Timothy Schwartz

ROCHE

Senior Scientific Affairs Manager, Next Generation Sequencing

Image

Sheetal Parmar

NATERA

VP, Medical Affairs

Image

Kunal Ramani

XERIS PHARMACEUTICALS

Regional Medical Affairs Director

Image

Stevan Tomich

XERIS PHARMACEUTICALS

Regional Medical Affairs Director

Image

Maria Picone

TREND COMMUNITY ENGAGEMENT

Co-Founder/CEO

Image

Martina Cartwright

CASSIOPEA

Senior Director, Medical Affairs

Image

Sherry Dunbar

LUMINEX CORPORATION

Senior Director, Global Scientific Affairs

Image

Jennifer Guzman

HELIXMITH

Senior Director, Medical Affairs Strategy

Image

Ana Bozas

AKCEA THERAPEUTICS

Associate Director, Global Medical Communications

Image

Alyson Evans

BIOHAVEN PHARMACEUTICALS

Associate Director/MSL

Image

Daniel Snyder

UROVANT SCIENCES, INC.

Vice President, Medical Affairs

Image

Imtiyaz Hossain

TAKEDA

Associate Director, Data Science Lead, Global Medical Affairs

Image

Nami Pandit

SANOFI GENZYME

Global Medical Affairs Director

Image

Maria Urso

EXACT SCIENCES

Director, Medical Affairs Field Team

Image

Antonio Maltese

TREND COMMUNITY ENGAGEMENT

Intern

Image

Rachael Brake

TAKEDA

Head, US Medical Affairs, Oncology

Image

Tina Purcell

ASTELLAS PHARMA

Associate Director, Medical Science Liaison, Oncology

Image

Tyke White

ALKERMES

Vice President, Scientific Engagement and Medical Information

Image

Svetlana Pidasheva

AXCELLA

Senior Director, Scientific Affairs

Image

Sherin Al-Safadi

BAYER PHARMACEUTICALS

Global Medical Affairs Strategy Lead, Oncology

Image

Elizabeth Pash

GELESIS

Vice President, Medical Affairs

Image

Suzanne Giordano

SUNOVION PHARMACEUTICALS

Executive Director and Head of MSLs

Image

Sherry Siegert

LA JOLLA PHARMACEUTICAL COMPANY

Director, Medical Affairs

Image

Wendy Wells

APELLIS PHARMACEUTICALS

Director, Medical Affairs Training

Image

Kunj Gohill

NOVARTIS

Director, Digital Strategy Lead, Digital Medical Affairs

Image

Peter Covitz

BIOGEN

Senior Director, Medical Affairs

Image

Shurjeel Choudhri

BAYER

Senior Vice President and Head, Medical and Scientific Affairs

Image

Luca Dezzani

EISAI

Vice President, U.S. Medical Affairs

Image

Becky Winslow

ADMERA HEALTH

Senior Clinical Specialist, Pharmacogenomics, Medical Affairs

Image

Marissa Caputo

CORINDUS VASCULAR ROBOTICS

Director of Medical Education and Medical Affairs

Image

Ivan Desviat

ABBVIE

Director, Medical Education & Outcome Measures Excellence

Image

Michael Kahn

SPARK THERAPEUTICS

Medical Affairs Operations Leader

Image

Edmond Kim

AMGEN

Global MCC Director, Medical Communications

Image

Ritam Priya

NOCIMED

Vice President and Regulatory

Image

Claudia Morato

ELI LILLY & COMPANY

Senior Global Medical Affairs, Oncology

Image

Jamie Weiss

Image

Jason Howard

SANOFI

Scientific Engagement & Medical Digital Lead

CONFERENCE REGISTRATION


VIRTUAL LIVE-STREAM PRICING

** Super Early Bird **

Before 11/20/20

$796

Early Bird

Before 12/18/20

$896

Standard

After 12/18/20

$996

Register 2 Attendees, Get 1 Complimentary Registration*!

Interested in sending groups of 7 or more? Contact us directly for pricing.

EVENT SPONSORS


SPONSOR THIS EVENT

Contact Amy Chapman at (561) 571-7687
or achapman@dgeconfs.com


MEDIA PARTNERS

Image

PREMIER MEDIA PARTNER